Medbox CEO Gives Testimony to DPH Regarding Program Implementation in Massachusetts

CEO also travels to Colorado to present to Amendment 64 state advisory panel

Feb 15, 2013, 09:04 ET from Medbox, Inc.

HOLLYWOOD, Calif., Feb. 15, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (, announced that their CEO, Dr. Bruce Bedrick, gave testimony earlier in the week to the Department of Public Health in support of sensible regulations and overall implementation of the medical marijuana program in Massachusetts. 

Dr. Bedrick was one of the first few speakers Wednesday in Worcester and gave testimony, in a standing room only crowd, directly to the DPH whom is charged with implementing the rules and procedures governing the Massachusetts medical marijuana program. Dr. Bedrick proposed easy and convenient access for patients to receive their medicine, but also suggested strict regulatory oversight to prevent abuse and diversion. Massachusetts will only be authorizing a total of 35 dispensaries licenses for the entire state and it is believed that the licensing of the facilities will be finalized by the end of this year.

The CEO was then off to Colorado Thursday where he presented the Amendment 64 advisory panel with an overview of the Medbox technology and how it would be used in Colorado to track taxation, limit abuse, and control inventory more effectively. The appearance in Colorado coincides with a news story on Fox News Denver (KDVR) that is set to air Wednesday February 20th at 9pm central that prominently features the Medbox technology and has interviews with Dr. Bedrick and an operator that utilizes the Medbox equipment in her dispensary to manage day-to-day operations.

"We are thrilled that regulatory agencies around the country are allowing us to speak with them on how to create a safe, compliant, and transparent model for operation," stated Dr. Bedrick. "Medbox prides itself on being an industry leader and an integral part of the solution and never part of the problem."

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to

SOURCE Medbox, Inc.